Don't miss this new IQVIA white paper that examines the FDA's initiatives toward encouraging earlier oncology studies via Project FrontRunner, offering practical regulatory guidance on engaging with the FDA and leveraging accelerated approval pathways to expedite patient access to new therapies.
What if patients could access life-saving treatments sooner? In the battle against cancer, every second counts. Dive into our latest white paper, where IQVIA's experts reveal how the FDA’s Project FrontRunner is reshaping oncology care and provide expert guidance to accelerate breakthroughs. Read the insights in full: https://lnkd.in/dKbHjEnF #CancerTreatment #DrugDevelopment #ProjectFrontRunner
